Cargando…
Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
Currently, interferon alpha and nucleos(t)ide analogues (NAs) are clinically available to treat hepatitis B virus (HBV) infection. Several NAs, including lamivudine (LMV), adefovir (ADV), entecavir (ETV) and tenofovir (TDF or TAF) have been approved and administered to chronic hepatitis B (CHB) pati...
Autores principales: | Won, Juhee, Lee, Ah Ram, Dezhbord, Mehrangiz, Lee, Da Rae, Kim, Seong Ho, Kim, Jong Chul, Park, Soree, Kim, Nayeon, Jae, Byengjune, Kim, Kyun-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312910/ https://www.ncbi.nlm.nih.gov/pubmed/35884942 http://dx.doi.org/10.3390/biomedicines10071637 |
Ejemplares similares
-
Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient
por: Kim, Jong Chul, et al.
Publicado: (2022) -
Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System
por: Lee, Ah Ram, et al.
Publicado: (2022) -
Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes
por: Lee, Ah Ram, et al.
Publicado: (2021) -
Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation
por: Park, Soree, et al.
Publicado: (2020) -
Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma
por: Park, Eun-Sook, et al.
Publicado: (2022)